VALIANT LABORATORIES
Back to Balance Sheet
|
VALIANT LABORATORIES Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | |
|---|---|---|---|---|
| Total Current Liabilities | ₹119 Cr | ₹60 Cr | ₹29 Cr | ₹51 Cr |
What is the latest Total Current Liabilities ratio of VALIANT LABORATORIES ?
| Year | Total Current Liabilities |
|---|---|
| Mar2026 | ₹119 Cr |
| Mar2025 | ₹60 Cr |
| Mar2024 | ₹29 Cr |
| Mar2023 | ₹51 Cr |
How is Total Current Liabilities of VALIANT LABORATORIES Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹119 Cr | 100.36 | |
| Mar2025 | ₹60 Cr | 105.03 | |
| Mar2024 | ₹29 Cr | -42.68 | |
| Mar2023 | ₹51 Cr | - | |
Compare Total Current Liabilities of peers of VALIANT LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VALIANT LABORATORIES | ₹607.1 Cr | -7.6% | -6.8% | 30.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹457,073.0 Cr | 7.3% | 8.4% | 13.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹307,147.0 Cr | 15.3% | 24.1% | 63% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹181,626.0 Cr | 1% | 2.5% | 33.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹115,685.0 Cr | 1% | 15.9% | 14% | Stock Analytics | |
| CIPLA | ₹113,589.0 Cr | 0.4% | 7.9% | -6.2% | Stock Analytics | |
VALIANT LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VALIANT LABORATORIES | -7.6% |
-6.8% |
30.3% |
| SENSEX | 5.5% |
13.3% |
-3.4% |
You may also like the below Video Courses